We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’ Substack by Kontra. In this article, we will summarize the bull’s thesis on TEVA. Teva Pharmaceutical Industries Limited's share was trading at $17.09 as of June 24th. TEVA’s trailing and forward P/E ratios were 872.00 and 6.53, respectively, according to Yahoo Finance.
[caption id="attachment_1238408" align="aligncenter" width="768"]Teva Pharmaceuticals is undergoing a strategic...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.